TY - JOUR
T1 - PROSE therapy used to minimize corneal trauma in patients with corneal epithelial defects
AU - Ling, Jeanie D.
AU - Gire, Anisa
AU - Pflugfelder, Stephen C.
N1 - Funding Information:
All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. S. Pflugfelder has the following disclosures: Allergan: consultant and grant support; Bausch and Lomb: consultant; Glaxo Smith Kline: consultant and grant support. Publication of this article was supported by the following: an unrestricted grant from Research to Prevent Blindness , New York, New York (S.C.P.); the Oshman Foundation , Houston, Texas (S.C.P.); the William Stamps Farish Fund , Houston, Texas (S.C.P.); Hamill Foundation , Houston, Texas (S.C.P.). Contributions of authors: involved in design and conduct of the study (S.C.P.); collection of data (S.C.P., J.L., A.G.); management (S.C.P.), analysis (J.L., S.C.P.), and interpretation of the data (J.L., S.C.P.); and preparation, review, and approval of the manuscript (J.L., S.C.P.).
Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 2013/4
Y1 - 2013/4
N2 - Purpose: To review the effectiveness of continuous or extended daily wear of Prosthetic Replacement of the Ocular Surface Ecosystem (PROSE) for treating recurrent or persistent corneal epithelial defects from a variety of causes that were refractory to conventional therapy in 9 patients. Design: Retrospective case series. Methods: The medical records of 9 patients with a history of recurrent or persistent corneal epithelial defects resistant to conventional medical treatment who received treatment at the Cullen Eye Institute between January 2011 and July 2012 were reviewed. Demographic information, etiology, prior treatment, and outcome of PROSE treatment were analyzed. Recurrence after cessation of PROSE and complications were also identified. Results: The etiologies of recurrent or persistent corneal epithelial defects in this series included neurotrophic keratopathy, lattice and Avellino dystrophy, Stevens-Johnson syndrome, and chemical/thermal injury. All patients were initially treated with bandage contact lens; however, continuous silicone hydrogel lens wear was not effective in preventing recurrence or healing corneal epithelial defects in all patients. Epithelial defects healed without recurrence in all 9 patients treated with PROSE. Eight patients developed recurrent epithelial defects when PROSE was discontinued, but rehealed after resuming PROSE. Visual acuity improved in 8 patients (88.9%) treated with PROSE. Conclusions: Complex persistent or recurrent corneal epithelial defects that failed to heal with extended silicone hydrogel contact lenses healed with PROSE. PROSE therapy was well tolerated, but corneal epithelial defects recurred in all but 1 case following cessation of therapy.
AB - Purpose: To review the effectiveness of continuous or extended daily wear of Prosthetic Replacement of the Ocular Surface Ecosystem (PROSE) for treating recurrent or persistent corneal epithelial defects from a variety of causes that were refractory to conventional therapy in 9 patients. Design: Retrospective case series. Methods: The medical records of 9 patients with a history of recurrent or persistent corneal epithelial defects resistant to conventional medical treatment who received treatment at the Cullen Eye Institute between January 2011 and July 2012 were reviewed. Demographic information, etiology, prior treatment, and outcome of PROSE treatment were analyzed. Recurrence after cessation of PROSE and complications were also identified. Results: The etiologies of recurrent or persistent corneal epithelial defects in this series included neurotrophic keratopathy, lattice and Avellino dystrophy, Stevens-Johnson syndrome, and chemical/thermal injury. All patients were initially treated with bandage contact lens; however, continuous silicone hydrogel lens wear was not effective in preventing recurrence or healing corneal epithelial defects in all patients. Epithelial defects healed without recurrence in all 9 patients treated with PROSE. Eight patients developed recurrent epithelial defects when PROSE was discontinued, but rehealed after resuming PROSE. Visual acuity improved in 8 patients (88.9%) treated with PROSE. Conclusions: Complex persistent or recurrent corneal epithelial defects that failed to heal with extended silicone hydrogel contact lenses healed with PROSE. PROSE therapy was well tolerated, but corneal epithelial defects recurred in all but 1 case following cessation of therapy.
UR - http://www.scopus.com/inward/record.url?scp=84875242316&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84875242316&partnerID=8YFLogxK
U2 - 10.1016/j.ajo.2012.09.033
DO - 10.1016/j.ajo.2012.09.033
M3 - Article
C2 - 23218704
AN - SCOPUS:84875242316
SN - 0002-9394
VL - 155
SP - 615-619.e2
JO - American Journal of Ophthalmology
JF - American Journal of Ophthalmology
IS - 4
ER -